<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00259220</url>
  </required_header>
  <id_info>
    <org_study_id>P040427</org_study_id>
    <secondary_id>AOM04093</secondary_id>
    <nct_id>NCT00259220</nct_id>
  </id_info>
  <brief_title>HDUPE 2004: Gastro-Oesophageal Haemorrhage in Emergency : Gastric Préparation to Endoscopy</brief_title>
  <official_title>In Urgency Hight Digestive Haemorrhage : Gastric Preparation for Endoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gastric lavage is usually used for gastric preparation before endoscopy in patients with
      upper gastrointestinal bleeding. However, the benefit-risk balance of putting a nasogastric
      tube in these patients is not clearly defined. This randomized trial is aimed to determine if
      the use of erythromycin IV before endoscopy could avoid to put a gastric tube for the
      management of upper gastrointestinal bleeding.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute upper gastrointestinal haemorrhage is one of the main digestive emergencies involving
      hospital admission. Endoscopic examination plays a key role to determine the cause of the
      bleeding and to carry out a therapeutic procedure. Endoscopic performance depends on the
      quality of the examination that may be hampered by residual blood in the gastric cavity.
      Gastric lavage is usually performed to clear the stomach. However, several teams consider
      that it is possible to avoid putting a nasogastric tube because it is ineffective in half of
      the patients, disagreeable in most of them, can induce side effects and need a long time work
      for nurses. It could be replaced by the use of Erythromycin. There are no official
      recommendations in that field. Recent studies have shown that Erythromycin, a macrolide
      antibiotic with gastro kinetic properties can accelerate gastric emptying by inducing gastric
      contraction. This motilin receptor agonist could improve the gastric cleaning and the quality
      of endoscopic examination and decrease its duration.

      This randomized trial is aimed to determine if the use of erythromycin IV before endoscopy
      could avoid putting a gastric tube for the management of upper gastrointestinal bleeding. It
      is a prospective, controlled, randomized, multicentric study with a blind assessment of the
      main criteria. All patients aged more than 18 years with an acute upper gastrointestinal
      bleeding, defined by melena or hematemesis, managed by emergency department are enrolled. 270
      patients are expected. Informed consent including for endoscopic examination and no
      contraindication for using Erythromycin (QT enlargement) is needed. Patients are randomized
      in three groups: Erythromycin alone, nasogastric tube with gastric lavage alone or both
      Erythromycin and nasogastric tube. Patients are followed-up until first month after bleeding.
      The main criteria are the visualization of the gastric tract and the other criteria are
      rebleeding until D 30, transfusion, gastric tube or erythromycin complications.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2005</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endoscopic yield</measure>
    <time_frame>at the beggining of the study</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rebleeding until D 30, transfusion, gastric tube or erythromycin complications</measure>
    <time_frame>until 30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">270</enrollment>
  <condition>Upper Gastrointestinal Bleeding</condition>
  <arm_group>
    <arm_group_label>drug</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>erythromycine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>gastric lavage alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>erythromycine and gastric lavage</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>erythomycin</intervention_name>
    <description>erythomycin</description>
    <arm_group_label>drug</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>gastric lavage alone</intervention_name>
    <description>gastric lavage alone</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>erythromycine and gastric lavage</intervention_name>
    <description>erythromycine and gastric lavage</description>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hematemesis or melaena

          -  No QT enlargement

        Exclusion Criteria:

          -  Refusing endoscopy

          -  Glasgow &lt; 15
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique PATERON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Jean VERDIER</name>
      <address>
        <city>Bondy</city>
        <zip>93140</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2005</study_first_submitted>
  <study_first_submitted_qc>November 28, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 29, 2005</study_first_posted>
  <last_update_submitted>September 30, 2008</last_update_submitted>
  <last_update_submitted_qc>September 30, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 1, 2008</last_update_posted>
  <responsible_party>
    <name_title>Myriem CARRIER</name_title>
    <organization>Department Clinical Research of Developpement</organization>
  </responsible_party>
  <keyword>Bleeding</keyword>
  <keyword>Endoscopy</keyword>
  <keyword>Gastric tube</keyword>
  <keyword>Erythromycin</keyword>
  <keyword>Randomized</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Gastrointestinal Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erythromycin</mesh_term>
    <mesh_term>Erythromycin Estolate</mesh_term>
    <mesh_term>Erythromycin Ethylsuccinate</mesh_term>
    <mesh_term>Erythromycin stearate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

